The synthesis of 4-styryl-substituted 2, 3,8-trioxabicyclo[3.3.1]nonanes, peroxides with the core structure of the bioactive 1,2,4-trioxane ring, was conducted by a multistep route starting from the aryl methyl ketones 1a-1c. Condensation and reduction/oxidation delivered enals 4a-4c that were coupled with ethyl acetate and reduced to the 1,3-diol substrates 6a-6c. Highly diastereoselective photooxygenation delivered the hydroperoxides 7a-7c and subsequent PPTS (pyridinium-p-toluenesulfonic acid)-catalyzed peroxyacetalization with alkyl triorthoacetates gave the cyclic peroxides 8a-8e. These compounds in general show only moderate antimalarial activities. In order to extend the repertoire of cyclic peroxide structure, we aimed for the synthesis of spiro-perorthocarbonates from orthoester condensation of β-hydroxy hydroperoxide 9 but could only realize the monocyclic perorthocarbonate 10. That the central peroxide moiety is the key structural motif in anticancer active GST (glutathione S-transferase)-inhibitors was elucidated by the synthesis of a 1,3-dioxane 15-with a similar substitution pattern as the pharmacologically active peroxide 11-via a singlet oxygen ene route from the homoallylic alcohol 12.
Introduction
The 2015 Nobel Prize in physiology and medicine awarded to the Chinese scientist Youyou Tu, for her discoveries concerning a novel therapy against malaria [1, 2] , honored a lifelong work in structure elucidation and investigations on mechanism of action of potent antimalarial drugs from folk medicine. The central compound in this research is the unusual peroxide artemisinin (in Chinese translation: qinghaosu), a structurally complex tetracyclic sesquiterpene lactone with an endoperoxide substructure that can be isolated from the leaves of Artemisia annua [3] [4] [5] [6] [7] [8] . Due to its very high antimalarial activities, artemisinin, its derivatives, and numerous analogs have become important as antimalarial drugs against multidrug-resistant forms of Plasmodium falciparum [9] . Recently, numerous reports have also described diverse antitumor activities of these compounds [10] [11] [12] [13] [14] . This high pharmacological potential combined with its synthetically challenging and chemically unusual structure have prompted synthetic chemists to design total or partial synthesis routes to this compound and derivatives thereof [15] [16] [17] [18] [19] [20] [21] [22] as well as the design of artemisinin dimers, conjugates and dyads [23] . In addition, flow chemistry has been applied in order to produce large amounts of artemisinin involving a photochemical key step [24] [25] [26] . With respect to the chemical reactivity of artemisinin derivatives, an ongoing discussion concerns the correlation between biological activity and the kind of peroxide-related steps that actually interfere with parasite-infected cells [27] [28] [29] [30] .
The central pharmacophore of natural artemisinin and derivatives is the 1,2,4-trioxane ring. A more detailed look at the artemisinin structure shows that this group is part of a bicyclo[3.2.2]nonane skeleton, i.e., not existing in a perfect cyclohexane chair conformation. Furthermore, not only a peracetal group but also an acetal is present in artemisinin and its dihydroderivative (DHA, with a further hemiactal structure) or DHA ethers like arthemether or artheether (corresponding to the methyl and ethyl ether of DHA, respectively). A structural simplification that has been extensively realized synthetically and examined with respect to antimalaria-activity is the 3-spiroannelated 1,2,4-trioxane structure [31] [32] [33] . We have recently started to explore synthetic routes to these compounds as well as to ring-contracted bicyclic peroxides with intact 1,2,4-trioxane units as well as to multifunctional trioxanes [34] [35] [36] . Additionally, molecular dyads that combine the natural artemisinin skeleton with synthetic trioxanes were realized by our group [37] [38] [39] . The synthetic protocol that we follow in this approach is depicted in Scheme 1: allylic alcohols A are highly reactive substrates for the singlet oxygen ene reaction and lead to β-hydroxy hydroperoxides B with high regio-and, in the case of chiral allylic alcohols, also high threo diastereoselectivity. Furthermore, Broensted or Lewis acid (boron trifluoride shown as a representative example) catalyzed peroxyacetalization of B, in the presence of ketones, aldehydes (R 3 R 4 C=O) or equivalent reagents (acetals or orthoesters), did eventually result in the formation of the desired 1,2,4-trioxanes C. From chiral 3,3-dimethylated substrates (R 1 =CH3), diastereoisomeric mixtures of threo and erythro oxygenation products are formed in ratios that are strongly solvent-dependent [40] . Arylated substrates (R 1 =Ar) result in even higher diastereoselectivities [41, 42] . We have now envisaged combining this selectivity-enhancing effect with the synthesis of multifunctional 2,3,8-trioxabicyclo[3.3.1]nonanes F, perorthoesters with the core structure of the bioactive 1,2,4-trioxane ring. From a structural point of view (Scheme 2, D = artemisinine), the combination of an additional (per)acetal group with the trioxane ring E appears to be an interesting new structural feature affecting the pharmacological properties of these compounds. 
Results and Discussion
The synthetic protocol for the synthesis of bicyclic perorthoesters G as shown in Scheme 3 requires the preparation of 1-hydroperoxy-2,4-diols that are, in turn, available from allylic alcohols H by singlet oxygen ene reactions. The route to the 1,3-diols 6a-6c starts with the Horner-WadsworthScheme 1. Synthetic route to 1,2,4-trioxanes using the singlet oxygen ene reaction.
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The synthetic protocol for the synthesis of bicyclic perorthoesters G as shown in Scheme 3 requires the preparation of 1-hydroperoxy-2,4-diols that are, in turn, available from allylic alcohols H by singlet oxygen ene reactions. The route to the 1,3-diols 6a-6c starts with the Horner-Wadsworth-Emmons olefination of aric ketones 1a-1c and subsequent reduction of the Michael esters 2a-2c with DIBAL-H or lithium aluminum hydride. The allylic alcohols 3a-3c were oxidized with MnO 2 to give the aldehydes 4a-4c. Aldol reaction with ethylacetate resulted in the aldols 5a-5c that were reduced to the 1,3-diols 6a-6c. The synthesis of the allylic hydroperoxides 7a-7c from the allylic alcohols 6 proceeded according to literature procedures published by us for solid state photooxygenation [32] [33] [34] . 
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This photooxygenation showed very high syn (threo) selectivity due to the well-known allylic hydroxy effect [40] . The selectivity was even higher (>95:5) as for the standard substrate 1,3-dimethyl-2-buten-1-ol (mesitylol, dr 85:15 under these conditions) because only the methyl group in Z-geometry to the stereogenic hydroxyl-substituted center is active in hydrogen transfer (Scheme 4). This high selectivity was also reported by Singh and coworkers for arylated (mono) allylic alcohols [41, 42] . The suprafacial approach of the highly electrophilic singlet oxygen that appears from the same side as the hydroxyl group is located, indicating a hydrogen bond interaction that stabilizes the transition state. This photooxygenation showed very high syn (threo) selectivity due to the well-known allylic hydroxy effect [40] . The selectivity was even higher (>95:5) as for the standard substrate 1,3-dimethyl-2-buten-1-ol (mesitylol, dr 85:15 under these conditions) because only the methyl group in Z-geometry to the stereogenic hydroxyl-substituted center is active in hydrogen transfer (Scheme 4). This high selectivity was also reported by Singh and coworkers for arylated (mono) allylic alcohols [41, 42] . The suprafacial approach of the highly electrophilic singlet oxygen that appears from the same side as the hydroxyl group is located, indicating a hydrogen bond interaction that stabilizes the transition state. The allylic hydroperoxides 7 were suitable substrates for the final peroxyacetalization. As carbonyl reagents, orthoesters were used because three condensation steps are necessary for the formation of the bicyclic products 8. As a Broensted acid catalyst, pyridinium-p-toluenesulfonic acid (PPTS) was used, and the products were obtained in moderate yields (20%-44%). Only the anisyl derivative 8d was formed in low yields of 8%. Because of the high threo-diastereoselectivity of the singlet oxygen ene reaction, the products were formed as preferentially as one diastereoisomer with a pseudo-equatorial conformation of the substituent R 1 (corresponding to the precursor with R*R*-configuration, Scheme 5). Antimalaria activities of these compounds were in the micromolar range [43] . The most active 1,2,4-trioxanes that we have obtained by analogous synthetic route showed in vitro activities against Plasmodium falciparum (K1 strain) in the 1-5 nM region [31] , one order of magnitude higher than the perorthoesters 8. In order to explore the synthetic limitations of the perorthoester synthesis, the condensation of β-hydroxy hydroperoxides with orthocarbonates was investigated. As a model compound, the allylic hydroperoxide 9 (available from the singlet oxygen reaction with mesitylol J) was used and treated with a substoechiometric amount of tetramethylorthocarbonate. The primary peroxyacetalization proceeded smoothly to give the perorthocarbonate 10 in 30%, but no further reactivity of 10 was detected (Scheme 6).
Scheme 6. Literature-known dimeric trioxane structure I [36] and envisaged synthetic approach to the hexaoxaspiro [5, 5] undecane structure K. Scheme 4. Regio-and diastereoselectivity controlling elements in the singlet oxygen ene reaction with allylic alcohols 6.
The allylic hydroperoxides 7 were suitable substrates for the final peroxyacetalization. As carbonyl reagents, orthoesters were used because three condensation steps are necessary for the formation of the bicyclic products 8. As a Broensted acid catalyst, pyridinium-p-toluenesulfonic acid (PPTS) was used, and the products were obtained in moderate yields (20%-44%). Only the anisyl derivative 8d was formed in low yields of 8%. Because of the high threo-diastereoselectivity of the singlet oxygen ene reaction, the products were formed as preferentially as one diastereoisomer with a pseudo-equatorial conformation of the substituent R 1 (corresponding to the precursor with R*R*-configuration, Scheme 5). Antimalaria activities of these compounds were in the micromolar range [43] . The most active 1,2,4-trioxanes that we have obtained by analogous synthetic route showed in vitro activities against Plasmodium falciparum (K1 strain) in the 1-5 nM region [31] , one order of magnitude higher than the perorthoesters 8. The allylic hydroperoxides 7 were suitable substrates for the final peroxyacetalization. As carbonyl reagents, orthoesters were used because three condensation steps are necessary for the formation of the bicyclic products 8. As a Broensted acid catalyst, pyridinium-p-toluenesulfonic acid (PPTS) was used, and the products were obtained in moderate yields (20%-44%). Only the anisyl derivative 8d was formed in low yields of 8%. Because of the high threo-diastereoselectivity of the singlet oxygen ene reaction, the products were formed as preferentially as one diastereoisomer with a pseudo-equatorial conformation of the substituent R 1 (corresponding to the precursor with R*R*-configuration, Scheme 5). Antimalaria activities of these compounds were in the micromolar range [43] . The most active 1,2,4-trioxanes that we have obtained by analogous synthetic route showed in vitro activities against Plasmodium falciparum (K1 strain) in the 1-5 nM region [31] , one order of magnitude higher than the perorthoesters 8. In order to explore the synthetic limitations of the perorthoester synthesis, the condensation of β-hydroxy hydroperoxides with orthocarbonates was investigated. As a model compound, the allylic hydroperoxide 9 (available from the singlet oxygen reaction with mesitylol J) was used and treated with a substoechiometric amount of tetramethylorthocarbonate. The primary peroxyacetalization proceeded smoothly to give the perorthocarbonate 10 in 30%, but no further reactivity of 10 was detected (Scheme 6). In order to explore the synthetic limitations of the perorthoester synthesis, the condensation of β-hydroxy hydroperoxides with orthocarbonates was investigated. As a model compound, the allylic hydroperoxide 9 (available from the singlet oxygen reaction with mesitylol J) was used and treated with a substoechiometric amount of tetramethylorthocarbonate. The primary peroxyacetalization proceeded smoothly to give the perorthocarbonate 10 in 30%, but no further reactivity of 10 was detected (Scheme 6). The allylic hydroperoxides 7 were suitable substrates for the final peroxyacetalization. As carbonyl reagents, orthoesters were used because three condensation steps are necessary for the formation of the bicyclic products 8. As a Broensted acid catalyst, pyridinium-p-toluenesulfonic acid (PPTS) was used, and the products were obtained in moderate yields (20%-44%). Only the anisyl derivative 8d was formed in low yields of 8%. Because of the high threo-diastereoselectivity of the singlet oxygen ene reaction, the products were formed as preferentially as one diastereoisomer with a pseudo-equatorial conformation of the substituent R 1 (corresponding to the precursor with R*R*-configuration, Scheme 5). Antimalaria activities of these compounds were in the micromolar range [43] . The most active 1,2,4-trioxanes that we have obtained by analogous synthetic route showed in vitro activities against Plasmodium falciparum (K1 strain) in the 1-5 nM region [31] , one order of magnitude higher than the perorthoesters 8. In order to explore the synthetic limitations of the perorthoester synthesis, the condensation of β-hydroxy hydroperoxides with orthocarbonates was investigated. As a model compound, the allylic hydroperoxide 9 (available from the singlet oxygen reaction with mesitylol J) was used and treated with a substoechiometric amount of tetramethylorthocarbonate. The primary peroxyacetalization proceeded smoothly to give the perorthocarbonate 10 in 30%, but no further reactivity of 10 was detected (Scheme 6). [36] and envisaged synthetic approach to the hexaoxaspiro [5, 5] undecane structure K. Scheme 6. Literature-known dimeric trioxane structure I [36] and envisaged synthetic approach to the hexaoxaspiro [5, 5] undecane structure K.
In recent publications, we have also demonstrated the new potential of cyclic peroxides from the 1,2,4-trioxane family to inhibit certain glutathione transferases (GSTs), an important class of detoxification enzymes that are upregulated by tumor cells [44, 45] . In order to demonstrate the relevance of the central peroxide ring system, we designed the synthesis of a 1,3-dioxane 15 (Scheme 7) that is structurally related to the biologically active 1,2,4-trioxane 11 (pNP = 4-nitrophenyl) [44] . The key synthetic step was again a singlet oxygen ene reaction with the homoallylic alcohol 12. In situ reduction of the hydroperoxide 13 with Me 2 S and acetalization delivered the dioxane 15. No inhibition of hpGST could be determined for this compound, which accounts for the relevance of the peroxidic 1,2,4-trioxane ring in bioactive compounds. In recent publications, we have also demonstrated the new potential of cyclic peroxides from the 1,2,4-trioxane family to inhibit certain glutathione transferases (GSTs), an important class of detoxification enzymes that are upregulated by tumor cells [44, 45] . In order to demonstrate the relevance of the central peroxide ring system, we designed the synthesis of a 1,3-dioxane 15 (Scheme 7) that is structurally related to the biologically active 1,2,4-trioxane 11 (pNP = 4-nitrophenyl) [44] . The key synthetic step was again a singlet oxygen ene reaction with the homoallylic alcohol 12. In situ reduction of the hydroperoxide 13 with Me2S and acetalization delivered the dioxane 15. No inhibition of hpGST could be determined for this compound, which accounts for the relevance of the peroxidic 1,2,4-trioxane ring in bioactive compounds. 
Experimental Section
Infrared spectra were obtained using a Perkin-Elmer 1600 series FTIR spectrometer (Perkin-Elmer, Walluf, Germany) and are given in cm −1 units. Solid samples are measured as CsI or KBr discs while liquids are measured as neat between two NaCl plates; the 1 H-NMR spectra were recorded on Bruker Avance 300, Bruker DPX 300 spectrometers (Bruker, Ettlingen, Germany) operating at 300 MHz, or on Bruker Avance 500 spectrometer (Bruker, Ettlingen, Germany) instruments operating at 500 MHz. Chemical shifts are reported as δ in ppm and the coupling constants J in Hz units. In all spectra, the solvent peaks were used as the internal standard. Solvents used are CDCl3 (δ = 7.24 ppm), DMSO-d6 (δ = 2.49 ppm), acetone-d6 (δ = 2.04 ppm), and MeOH-d4 (δ = 3.35, 4.78 ppm). Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; the 13 C-NMR spectra were recorded either on a Bruker Avance 300 spectrometer instrument operating at 75 MHz or on a Bruker Avance 500 spectrometer instrument operating at 125 MHz; high resolution mass spectra (HR-MS) were recorded on a Finnigan MAT 900 spectrometer(Scientific Instrument Services, Ringoes, NJ, USA) and are measured for the molecular ion peak (M + ); CHN-combustion analyses were measured using an Elementar Vario EL Instrument (Elementar, Langenselbold, Germany).
General Procedures (GP)
GP-1: Horner-Wadsworth-Emmons reaction. In a flame-dried 200 mL three-necked flask in a nitrogen atmosphere, sodium hydride (60% dispersion in oil) was washed with hexane and suspended in THF. Triethylphosphonoacetate was dropped to the suspension at 0 °C over 10 min and stirred at r.t. for 30 min. After that, a solution of the ketone in THF was added in 10 min and the reaction mixture heated to reflux for 10 h. After cooling to r.t., an aqueous NH4Cl solution was added and extracted with 4× diethylether. The organic phases were washed with brine and dried over Na2SO4. After solvent evaporation, the product was purified by column chromatography.
GP-2: Reduction with DIBAL-H (diisobutylaluminium hydride). A solution of DIBAL-H (1.5 M in toluene) was slowly added to a solution of the ester 2 in diethylether cooled to 0 °C and subsequently 
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General Procedures (GP)
GP-1: Horner-Wadsworth-Emmons reaction. In a flame-dried 200 mL three-necked flask in a nitrogen atmosphere, sodium hydride (60% dispersion in oil) was washed with hexane and suspended in THF. Triethylphosphonoacetate was dropped to the suspension at 0 • C over 10 min and stirred at r.t. for 30 min. After that, a solution of the ketone in THF was added in 10 min and the reaction mixture heated to reflux for 10 h. After cooling to r.t., an aqueous NH 4 Cl solution was added and extracted with 4× diethylether. The organic phases were washed with brine and dried over Na 2 SO 4 . After solvent evaporation, the product was purified by column chromatography.
GP-2: Reduction with DIBAL-H (diisobutylaluminium hydride)
. A solution of DIBAL-H (1.5 M in toluene) was slowly added to a solution of the ester 2 in diethylether cooled to 0 • C and subsequently stirred at r.t. for 2 h. After dilution with diethylether (twice the solvent volume of the starting reaction) and cooling to 0 • C, saturated aqueous NaCl solution was added slowly, the pH was adjusted to 3 with 4 M HCl, and the aqueous phase was extracted with 3× diethylether. The organic phases were washed with brine and dried over Na 2 SO 4 . After solvent evaporation, the product was purified by column chromatography.
GP-3: Oxidation with MnO 2 . A suspension of MnO 2 in a toluene solution of the alcohol 3 was stirred overnight at RT. Afterwards, the reaction mixtures were filtered over celite and the solvent was evaporated. The crude product was purified by column chromatography.
GP-4: Aldol reactions with ethyl acetate. A solution of n-BuLi in hexane (19.2 mmol, 2 M) was added at −78 • C to a solution of diisopropylamine (19.2 mmol) in 40 mL of THF. After stirring for 5 min, ethyl acetate (16 mmol) was added and the mixture stirred at −78 • C for 2 h. Afterwards, the aldehyde 4 in 10 mL of THF was added and stirred for 5 min, warmed to −20 • C and quenched with 20 mL of 1 N HCl. The aqueous phase was extracted with 3× diethylether. The organic phases were washed with brine and dried over Na 2 SO 4 . After solvent evaporation, the product was purified by column chromatography.
GP-5: Reduction of aldols with NaBH 4 . In a flame-dried 200 mL three-necked flask in a nitrogen atmosphere, the aldol was dissolved in THF, cooled to 0 • C and NaBH 4 was added in one portion. Afterwards, a solution of iodine in THF was slowly added and the reaction mixture heated to reflux for 3 h. After cooling to RT, methanol was carefully added until a clear solution resulted, stirred for 30 min and the solvent evaporated. The colorless residue was dissolved in a 1:1 water-diethylether solvent mixture, stirred for 20 min, separated and the aqueous phase extracted with 3× diethylether. The organic phases were washed with brine and dried over Na 2 SO 4 . After solvent evaporation, the product was purified by column chromatography.
GP-6a: Photooxygenation under homogeneous conditions. The substrate (1 mmol) was dissolved in 30 mL of CCl 4 and 3-5 mg (2-4 × 10 −4 M) of the sensitizer TPP (meso-tetraphenylporphyrin) were added. The solution was cooled to 10 • C and irradiated with a white LED under oxygen atmosphere until complete conversion (TLC = thin layer chromatography control). Subsequently, the solvent was evaporated and the residue analyzed by NMR. The crude hydroperoxides were directly used for peroxyacetalization.
GP-6b: Photooxygenation under polymer matrix conditions. Commercially available polystyrenedivinylbenzene copolymer beads (2.5 g) are distributed over a Petri dish (19 cm diameter) and swollen by CH 2 Cl 2 (20 mL). The substrate (ca. 10 mmol) and the nonpolar sensitizer (TPP or TTP, ca. 3-6 mg) in ethyl acetate (20 mL) are subsequently added and the excess solvent is evaporated by leaving the Petri dish in a well ventilated hood. The Petri dish is then covered with a glass plate and the sandy solid is irradiated with a halogen lamp or a sodium street lamp. The polymer beads are subsequently rinsed with ethanol (3 × 30 mL) and filtered (the beads are kept for regeneration and reuse). The solvent is evaporated under reduced pressure (caution: water bath temperature should not exceed 30 • C).
GP-7a: Peroxyacetalization to give bicyclic perorthoesters. To a stirred solution of the β-hydroxy hydroperoxide 7 (1 mmol) and 3 equivalents of an orthoester in dry CH 2 Cl 2 (12 mL) was added at room temperature a catalytic amount of pyridinium-p-toluenesulfonic acid (PPTS) (ca. 10 mg) and the mixture was further stirred for about 12 h (overnight) at the same temperature. The reaction mixture was partitioned between CH 2 Cl 2 and saturated NaHCO 3 solution and the phases were separated. The aqueous phase was extracted with CH 2 Cl 2 (3 × 30 mL) and the combined organic phases were washed with brine and water, and dried over Na 2 SO 4 . Solvent evaporation (caution: water bath temperature should not exceed 30 • C) followed by chromatographic purification afforded the bicyclic perorthoesters as pure products.
GP-7b: Peroxyacetalization to give monocyclic 1,2,4-trioxanes. To a stirred solution of the β-hydroxy hydroperoxide and 1.5 equivalents of the carbonyl component in dry CH 2 Cl 2 (100 mL) was added at room temperature a catalytic amount of boron trifluoride etherate (ca. 0.2 mL) and the mixture was further stirred for about 12 h (overnight) at the same temperature. The reaction mixture was partitioned between CH 2 Cl 2 and saturated NaHCO 3 solution and the phases were separated. The aqueous phase was extracted with CH 2 Cl 2 (3 × 30 mL) and the combined organic phases were washed with brine and water, and dried over Na 2 SO 4 . Solvent evaporation (caution: water bath temperature should not exceed 30 • C), followed by chromatographic purification, afforded the spiro-bistrioxanes as pure products.
(E)-Ethyl-3-phenylbut-2-enoate (2a) [46] . Following GP-1 (General Procedure 1), 1.61 g (13.4 mmol) of acetophenone (1a) and 6.86 g (34.6 mmol, 2.6 eq) of triethylphosphono acetate and 1.33 g (33.4 mmol, 2.5 eq) of sodium hydride in 40 mL THF were reacted. The product was purified by column chromatography (CH/Et 2 O = 9:1, R f = 0.22) and isolated as yellow oil: 2.0 g, 10.5 mmol, 78%. 1 (E)-3-Phenylbut-2-enol (3a) [47] . Following GP-2 (General Procedure 2), 335 mg (1.76 mmol) of ester 2a was reduced with 3.52 mL DIBAL-H (3.52 mmol, 2 eq, 1H solution in hexane) in 16 mL of diethylether. The product 3a was purified by column chromatography (PE/Et 2 O 9:1, R f = 0.12) and isolated as colorless oil: 170 mg, 1.23 mmol, 70%. (E)-3-Phenylbut-2-enal (4a) [48] . (E)-4-Methoxyethyl-3-phenylbut-2-enoate (2b) [49] . Following GP-1, 2.00 g (13.4 mmol) of 4-methoxy acetophenone (1b) and 6.86 g (34.6 mmol, 2.6 eq) of triethylphosphono acetate and 1.33 g (33.4 mmol, 2.5 eq) of sodium hydride in 40 mL THF were reacted. The product was purified by column chromatography (CH/Et 2 O = 9:1, R f = 0.24) and isolated as yellow oil: 2.3 g, 10.4 mmol, 77%. 1 (E)-3-(4-Methoxyphenyl)but-2-ene-1-ol (3b) [50] . Following GP-2, 2.00 g (10.5 mmol) of ester 2b was reduced with 21 mL DIBAL-H (21 mmol, 2 eq, 1 M solution in hexane) in 60 mL of diethylether. The product 3b was purified by column chromatography (PE/Et 2 O 9:1, R f = 0.10) and isolated as colorless oil: (E)-3-(4-Methoxyphenyl)but-2-enal (4b) [51] . Following GP-3, 1.79 g (10.1 mmol) of the alcohol 4a and 18 g of MnO 2 in 250 mL of toluene were reacted. The product was purified by column chromatography (PE/Et 2 O = 1:1, R f = 0.28) and isolated as colorless oil: 1.79 g (6.9 mmol, 68%). 
